Skip to content

Clinical trials

Phase 3 Hepatitis C, Chronic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 3 Country / region: France Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20032
20043
20052
20064
20073
20081
20092
20101
20114
20126
20132
20141
20151
20173
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Terminated5
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
French National Agency for Research on AIDS and Viral Hepatitis5
Boehringer Ingelheim4
AbbVie3
Gilead Sciences3
Hoffmann-La Roche3
Janssen-Cilag International NV3
Debiopharm International SA2
GlaxoSmithKline2
Human Genome Sciences Inc.2
ANRS, Emerging Infectious Diseases1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic39
Hepatitis C17
Hepatitis4
Fibrosis3
Infections2
Acquired Immunodeficiency Syndrome1
Carcinoma, Hepatocellular1
Death1
Digestive System Diseases1
Enterovirus Infections1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.